Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-04-10 @ 3:07 AM
Study NCT ID:
NCT03371693
Status:
UNKNOWN
Last Update Posted:
2020-05-29
First Post:
2017-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
Sponsor:
Zhongnan Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-11-27
First Submit QC Date:
None
Study First Post Date:
2017-12-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-28
Last Update Post Date:
2020-05-29
Last Update Post Date Type:
ACTUAL